11.09.2018 • News

BioAmber Directors Resign

BioAmber Directors resign
BioAmber Directors resign

All the directors and officers of bankrupt Canadian biosuccinic acid producer BioAmber and its subsidiaries resigned on Aug. 31, leaving PricewaterhouseCoopers (PwC) to continue with the company’s liquidation.

On Aug 28, a Quebec court extended until Sept. 18 the creditors’ protection period under Canadian law to allow time for transactions from 11 bids for the Sarnia plant to be finalized.  The bids are said to include two from “strategic buyers.”

Production at the plant was shut down in late August, and most of the company’s 60 employees have left. The plant, which was commissioned in 2015, cost $140 million to build and made succinic acid from corn syrup.

BioAmber filed for court protection in May after if faced a liquidity crisis and was unable to raise money on public markets following its delisting from the New York and Toronto Stock Exchanges.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.